Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.
2.

PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB network.

Badagnani I, Sorani M, Edwards RH, Brown C, Castro RA, Huang CC, Stryke D, Kawamoto M, Johns SJ, Carlson EJ, Taylor T, Chan W, De La Cruz M, Ferrin TE, Burchard EG, Herskowitz I, Kroetz DL, Giacomini KM.

Pharmacol Rev. 2006 Mar;58(1):5-6. No abstract available.

PMID:
16507879
3.

PharmGKB submission update: V. PMT submissions of genetic variation in SLC22 family transporters.

Shu Y, Urban TJ, Leabman MK, Fujita T, Erdman AR, Lagpacan LL, Brown C, Castro RA, Huang CC, Stryke D, Kawamoto M, Johns SJ, Taylor TR, Chan W, De La Cruz M, Carlson EJ, Ferrin TE, Brett CM, Burchard EG, Herskowitz I, Kroetz DL, Giacomini KM.

Pharmacol Rev. 2006 Mar;58(1):3-4. No abstract available.

PMID:
16507878
5.

The Smk1p MAP kinase negatively regulates Gsc2p, a 1,3-beta-glucan synthase, during spore wall morphogenesis in Saccharomyces cerevisiae.

Huang LS, Doherty HK, Herskowitz I.

Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12431-6. Epub 2005 Aug 22.

6.

Cell polarity protein Spa2P associates with proteins involved in actin function in Saccharomyces cerevisiae.

Shih JL, Reck-Peterson SL, Newitt R, Mooseker MS, Aebersold R, Herskowitz I.

Mol Biol Cell. 2005 Oct;16(10):4595-608. Epub 2005 Jul 19.

7.

Genomic dissection of the cell-type-specification circuit in Saccharomyces cerevisiae.

Galgoczy DJ, Cassidy-Stone A, LlinĂ¡s M, O'Rourke SM, Herskowitz I, DeRisi JL, Johnson AD.

Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18069-74. Epub 2004 Dec 16.

8.

PharmGKB update: III. Genetic variants of SLC22A1, solute carrier family 22 (organic cation transporter), member 1.

Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, Ferrin TE, Herskowitz I, Giacomini KM.

Pharmacol Rev. 2004 Jun;56(2):161. No abstract available.

PMID:
15169925
9.

Anatomy and dynamics of DNA replication fork movement in yeast telomeric regions.

Makovets S, Herskowitz I, Blackburn EH.

Mol Cell Biol. 2004 May;24(9):4019-31.

10.

The Cdk-activating kinase Cak1p promotes meiotic S phase through Ime2p.

Schindler K, Benjamin KR, Martin A, Boglioli A, Herskowitz I, Winter E.

Mol Cell Biol. 2003 Dec;23(23):8718-28.

11.

Unique and redundant roles for HOG MAPK pathway components as revealed by whole-genome expression analysis.

O'Rourke SM, Herskowitz I.

Mol Biol Cell. 2004 Feb;15(2):532-42. Epub 2003 Oct 31.

12.

Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Carlson EJ, Herskowitz I, Giacomini KM, Clark AG; Pharmacogenetics of Membrane Transporters Investigators.

Pharmacogenetics. 2003 Aug;13(8):481-94. Erratum in: Pharmacogenetics. 2003 Nov;13(11):701.

PMID:
12893986
13.

PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2).

Leabman MK, Huang CC, Stryke D, Johns SJ, Kawamoto M, Ferrin TE, DeYoung J, Taylor TR, De La Cruz M, Herskowitz I, Giacomini KM.

Pharmacol Rev. 2003 Sep;55(3):399. Epub 2003 Jul 17. Review. No abstract available.

PMID:
12869664
14.

Control of landmark events in meiosis by the CDK Cdc28 and the meiosis-specific kinase Ime2.

Benjamin KR, Zhang C, Shokat KM, Herskowitz I.

Genes Dev. 2003 Jun 15;17(12):1524-39. Epub 2003 Jun 3.

15.

Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1.

Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, Wang J, Ferrin TE, Herskowitz I, Giacomini KM.

Pharmacogenetics. 2003 May;13(5):297-301.

PMID:
12724623
16.

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1.

Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, Ferrin TE, Herskowitz I, Giacomini KM; Pharmacogenetics Of Membrane Transporters Investigators.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):5902-7. Epub 2003 Apr 28.

17.

Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.

Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Urban TJ, Kroetz DL, Ferrin TE, Clark AG, Risch N, Herskowitz I, Giacomini KM; Pharmacogenetics Of Membrane Transporters Investigators.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):5896-901. Epub 2003 Apr 28.

18.

Polo-like kinase Cdc5 promotes chiasmata formation and cosegregation of sister centromeres at meiosis I.

Clyne RK, Katis VL, Jessop L, Benjamin KR, Herskowitz I, Lichten M, Nasmyth K.

Nat Cell Biol. 2003 May;5(5):480-5.

PMID:
12717442
19.

SNP analysis and presentation in the Pharmacogenetics of Membrane Transporters Project.

Stryke D, Huang CC, Kawamoto M, Johns SJ, Carlson EJ, Deyoung JA, Leabman MK, Herskowitz I, Giacomini KM, Ferrin TE.

Pac Symp Biocomput. 2003:535-47.

20.
21.

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals.

Ishida S, Lee J, Thiele DJ, Herskowitz I.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14298-302. Epub 2002 Oct 7.

22.

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.

Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Clark AG, Herskowitz I, Giacomini KM; Pharmacogenetics of Membrane Transporters Investigators.

Pharmacogenetics. 2002 Jul;12(5):395-405.

PMID:
12142729
23.

Yeast go the whole HOG for the hyperosmotic response.

O'Rourke SM, Herskowitz I, O'Shea EK.

Trends Genet. 2002 Aug;18(8):405-12. Review.

PMID:
12142009
25.

Regulating natural health products.

Herskowitz I.

Science. 2002 Apr 5;296(5565):46-7. No abstract available.

PMID:
11962491
26.

The 2001 Thomas Hunt Morgan Medal. Yasuji Oshima.

Herskowitz I, O'Shea E.

Genetics. 2002 Feb;160(2):367-8. No abstract available.

27.

The Khd1 protein, which has three KH RNA-binding motifs, is required for proper localization of ASH1 mRNA in yeast.

Irie K, Tadauchi T, Takizawa PA, Vale RD, Matsumoto K, Herskowitz I.

EMBO J. 2002 Mar 1;21(5):1158-67.

28.

The protein kinase Pho85 is required for asymmetric accumulation of the Ash1 protein in Saccharomyces cerevisiae.

McBride HJ, Sil A, Measday V, Yu Y, Moffat J, Maxon ME, Herskowitz I, Andrews B, Stillman DJ.

Mol Microbiol. 2001 Oct;42(2):345-53.

29.

Induction of distinct [URE3] yeast prion strains.

Schlumpberger M, Prusiner SB, Herskowitz I.

Mol Cell Biol. 2001 Oct;21(20):7035-46.

30.

Ash1p is a site-specific DNA-binding protein that actively represses transcription.

Maxon ME, Herskowitz I.

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1495-500.

31.

Post-transcriptional regulation through the HO 3'-UTR by Mpt5, a yeast homolog of Pumilio and FBF.

Tadauchi T, Matsumoto K, Herskowitz I, Irie K.

EMBO J. 2001 Feb 1;20(3):552-61.

32.

The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.

Schlumpberger M, Wille H, Baldwin MA, Butler DA, Herskowitz I, Prusiner SB.

Protein Sci. 2000 Mar;9(3):440-51.

33.

The ins and outs of cell-polarity decisions.

O'Shea EK, Herskowitz I.

Nat Cell Biol. 2000 Mar;2(3):E39-41.

PMID:
10707093
34.

Hospital merger leaves clinical science intact.

Stryker MP, Basbaum A, DeFranco T, Herskowitz I, Yamamoto K.

Nature. 1999 Oct 28;401(6756):842. No abstract available.

PMID:
10553895
35.

Genetic and biochemical characterization of the yeast spo12 protein.

Grether ME, Herskowitz I.

Mol Biol Cell. 1999 Nov;10(11):3689-703.

36.

The shower

Herskowitz I I.

Curr Biol. 1999 Oct 7;9(19):R713. No abstract available.

37.
38.

O-Glycosylation of Axl2/Bud10p by Pmt4p is required for its stability, localization, and function in daughter cells.

Sanders SL, Gentzsch M, Tanner W, Herskowitz I.

J Cell Biol. 1999 Jun 14;145(6):1177-88.

39.

Coming early to the late genes.

Herskowitz I.

Curr Biol. 1998 Nov 19;8(23):R827-8. Review. No abstract available.

40.

The role of Far1p in linking the heterotrimeric G protein to polarity establishment proteins during yeast mating.

Butty AC, Pryciak PM, Huang LS, Herskowitz I, Peter M.

Science. 1998 Nov 20;282(5393):1511-6.

42.

The transcriptional program of sporulation in budding yeast.

Chu S, DeRisi J, Eisen M, Mulholland J, Botstein D, Brown PO, Herskowitz I.

Science. 1998 Oct 23;282(5389):699-705. Erratum in: Science 1998 Nov 20;282(5393):1421.

43.
45.
46.

Genes to Cells in Mishima.

Herskowitz I, Stahl FW.

Genes Cells. 1998 Jan;3(1):1-8. No abstract available.

47.

Death-defying yeast identify novel apoptosis genes.

Shaham S, Shuman MA, Herskowitz I.

Cell. 1998 Feb 20;92(4):425-7. Review. No abstract available.

48.

Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast.

Henchoz S, Chi Y, Catarin B, Herskowitz I, Deshaies RJ, Peter M.

Genes Dev. 1997 Nov 15;11(22):3046-60.

49.

Osmotic balance regulates cell fusion during mating in Saccharomyces cerevisiae.

Philips J, Herskowitz I.

J Cell Biol. 1997 Sep 8;138(5):961-74.

50.

Actin-dependent localization of an RNA encoding a cell-fate determinant in yeast.

Takizawa PA, Sil A, Swedlow JR, Herskowitz I, Vale RD.

Nature. 1997 Sep 4;389(6646):90-3.

PMID:
9288973

Supplemental Content

Loading ...
Support Center